These data corroborate the suggestion that the FTO gene does not exert its effects on BMI and obesity through functional mutations, and that this effect is more likely to be exerted by the intron 1 of the FTO gene regulating the expression of the IRX3 and IRX5 loci, vital for adipocyte maturation [6, 7]. The gene discussed is FTO; the disease is obesity disorder.